Rofecoxib, also known as Vioxx, is a nonsteroidal anti-inflammatory drug (NSAID) that was prescribed to treat pain, fever, and inflammation. It was approved by the U.S. Food and Drug Administration (FDA) in 1999, but it was withdrawn from the market in 2004 due to concerns about the risk of cardiovascular problems associated with its use. Rofecoxib works by inhibiting the activity of cyclooxygenase (COX)-2, an enzyme that produces substances involved in inflammation. It is not recommended for long-term use due to the potential for serious side effects.
Rofecoxib, also known by the brand name Vioxx (withdrawn from the market in 2004), was a medication belonging to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs are commonly used to treat pain and inflammation. Here's a closer look at Rofecoxib:
What it did:
- Rofecoxib specifically targeted an enzyme called cyclooxygenase-2 (COX-2). COX-2 is involved in inflammation and pain pathways. By inhibiting COX-2, Rofecoxib aimed to reduce inflammation and alleviate pain.
- It was intended to treat various conditions causing pain and inflammation, including:
- Osteoarthritis
- Rheumatoid arthritis
- Acute pain (e.g., post-surgery)
- Primary dysmenorrhea (painful menstrual cramps)
- Migraine headaches
Why it's no longer available:
- In 2004, the manufacturer voluntarily withdrew Rofecoxib from the market due to safety concerns. Studies revealed an increased risk of heart attack and stroke associated with long-term use.
Alternative NSAIDs:
- Several other NSAIDs are available that offer pain relief and anti-inflammatory effects. These medications may have different side effect profiles, so consulting a doctor is crucial to determine the most suitable option for your individual needs.